SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001017491-18-000092
Filing Date
2018-10-17
Accepted
2018-10-16 20:57:57
Documents
8
Period of Report
2018-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kon10x16x18.htm 8-K 92187
2 EXHIBIT 2.1 ex21to8-kon10x16x18.htm EX-2.1 16807
3 EXHIBIT 3.1 ex31to8-kon10x16x18.htm EX-3.1 10061
4 EXHIBIT 4.1 ex41to8-kon10x16x18.htm EX-4.1 224452
5 EXHIBIT 4.2 ex42to8-kon10x16x18.htm EX-4.2 217129
6 EXHIBIT 10.1 ex101to8-kon10x16x18.htm EX-10.1 423844
7 EXHIBIT 10.2 ex102to8-kon10x16x18.htm EX-10.2 154906
8 EXHIBIT 10.3 ex103to8-kon10x16x18.htm EX-10.3 27866
  Complete submission text file 0001017491-18-000092.txt   1168575
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 181125300
SIC: 2834 Pharmaceutical Preparations